In the second part of their discussion on mitral valve disease prognostic indicators, Jose and Kieran talk about what echo measurements provide the most useful assessment of prognosis in stage B disease, consider whether there is a place for using cardiac biomarkers in monitoring pre-clinical dogs, and review the recent literature covering how best to predict progression in pre-clinical dogs.